Heinzelmann / Francis Lab / Ovarian Cancer Research

Frei, C.A. et al. (2025) ‘The chromatin guardian ATRX is a strong prognostic biomarker in melanoma’, Scientific Reports [Preprint]. Available at: https://doi.org/10.1038/s41598-025-30842-4.

Mehra, T. et al. (2025) ‘Comparative cost analysis of a diagnostic multi-omics platform for decision support in advanced cancer – results from the Tumor Profiler Melanoma project’, npj Precision Oncology [Preprint]. Available at: https://doi.org/10.1038/s41698-025-01229-5.

Lischetti, U. et al. (2025) ‘Ovarian cancer metastasis to the human omentum disrupts organ homeostasis and induces fundamental tissue reprogramming’, Nature Communications [Preprint]. Available at: https://doi.org/10.1038/s41467-025-67557-z.

Lischetti, Ulrike et al. (2025) ‘Ovarian cancer metastasis to the human omentum disrupts organ homeostasis and induces fundamental tissue reprogramming’, Nature Communications [Preprint]. Available at: https://doi.org/10.1038/s41467-025-67557-z.

Vigo, Francesco et al. (2025) ‘Binary classification of gynecological cancers based on ATR-FTIR spectroscopy and machine learning using urine samples’, Clinical and Experimental Medicine, 25. Available at: https://doi.org/10.1007/s10238-025-01684-1.

Petousis, Stamatios et al. (2025) ‘PARP Inhibitor Maintenance After First-Line Chemotherapy in Advanced-Stage Epithelial Ovarian Cancer: A Systematic Review and Meta-Analysis’, JAMA Network Open, 8(11). Available at: https://doi.org/10.1001/jamanetworkopen.2025.41648.

Ge, Isabell et al. (2025) ‘Evidenz, Forschungsmethodik und Qualitätskriterien in der Integrativen Onkologie: Grundlagen, Konsens und Perspektiven’, Therapeutische Umschau. Revue therapeutique. 01.11.2025, 82(5), pp. 157–162. Available at: https://doi.org/10.23785/TU.2025.05.003.

Kalbermatten,Natalie et al. (2025) ‘Gemeinsamkeiten und Kerndisziplinen der Integrativen Onkologie’, Therapeutische Umschau. Revue therapeutique. 01.11.2025, 82(5), pp. 144–162. Available at: https://doi.org/10.23785/TU.2025.05.002.

Psilopatis, Iason et al. (2025) ‘A comparative evaluation of publicly available large language models in the assessment of CTG traces according to the FIGO criteria’, Archives of Gynecology and Obstetrics. 21.08.2025, 312, pp. 1571–1580. Available at: https://doi.org/10.1007/s00404-025-08145-w.

Bollhagen, Alina et al. (2025) ‘High-resolution imaging mass cytometry to map subcellular structures’, Nature Methods [Preprint]. Available at: https://doi.org/10.1038/s41592-025-02889-8.

El Hajj, H. et al. (2025) ‘Best original research presented at the 26th European Congress on Gynaecological Oncology: Best of ESGO 2025’, International Journal of Gynecological Cancer, 35, p. 101932. Available at: https://doi.org/10.1016/j.ijgc.2025.101932.

Zwimpfer, T.A. et al. (2025) ‘Beyond BRCA deficiency: Clinical and molecular predictors of survival in patients with BRCA -deficient tubo-ovarian high-grade serous carcinoma’. Cold Spring Harbor Laboratory. Available at: https://doi.org/10.1101/2025.09.17.25335919.

Eller, R.S. et al. (2025) ‘1202P Revisiting radiotherapy: A forgotten ally in recurrent ovarian cancer treatment? A single-center retrospective cohort study’, Annals of Oncology, 36, pp. S733–S733. Available at: https://doi.org/10.1016/j.annonc.2025.08.1837.

Eugster-Disler, Muriel et al. (2025) ‘Cesarean scar niche repair with the rendez-vous technique: comparison of pre- and postoperative symptoms, sonographic findings and quality of life’, European Journal of Obstetrics and Gynecology and Reproductive Biology, 313. Available at: https://doi.org/10.1016/j.ejogrb.2025.114566.

Christinat, Yann et al. (2025) ‘Geneva Homologous Recombination Deficiency Test Is Predictive of Survival Benefit from Olaparib and Bevacizumab Maintenance in Ovarian Cancer’, JCO Precision Oncology, 9. Available at: https://doi.org/10.1200/po-24-00825.

Kacperczyk-Bartnik, J. et al. (2025) ‘Declaration on cervical cancer elimination: literature review and perspectives from early-career clinicians’, International Journal of Gynecological Cancer, 35(7), p. 101902. Available at: https://doi.org/10.1016/j.ijgc.2025.101902.

Todorov, Tihomir Zh. et al. (2025) ‘161Tb-Based Anti-L1CAM Radioimmunotherapy Shows Superior Efficacy in Eliminating Ovarian Cancer Stem Cells Compared with 177Lu in Preclinical Models of Ovarian Cancer’, Journal of Nuclear Medicine, 66, pp. 1091–1096. Available at: https://doi.org/10.2967/jnumed.124.269078.

Zwimpfer, Tibor A. and Montavon, Céline (2025) ‘Individualized strategies for a heterogeneous patient group - Gynecological tumors in older patients’, Schweizer Zeitschrift Fur Gynakologie, 2, pp. 18–22.

Einig, Sabrina et al. (2025) ‘External validation of the IOTA two-step strategy in the preoperative characterization of ovarian masses’, European Journal of Obstetrics and Gynecology and Reproductive Biology, 310. Available at: https://doi.org/10.1016/j.ejogrb.2025.113981.

Einig, Sabrina et al. (2025) ‘External validation of the IOTA two-step strategy in the preoperative characterization of ovarian masses’, European Journal of Obstetrics and Gynecology, 310. Available at: https://doi.org/10.1016/j.ejogrb.2025.113981.

Chinczewski, Lukas et al. (2025) ‘Intergroup-statement: statement of the german ovarian cancer commission, the North-Eastern German Society of gynecological Oncology (NOGGO), AGO Austria and AGO Swiss regarding the use of homologous repair deficiency (HRD) assays in advanced ovarian cancer’, Archives of Gynecology and Obstetrics, 311, pp. 1445–1450. Available at: https://doi.org/10.1007/s00404-025-07991-y.

Pölcher, Martin et al. (2025) ‘Intergroup statement: opportunistic salpingectomy—molecular pathology, clinical outcomes and implications for practice (German Ovarian Cancer Commission, the North-Eastern German Society of Gynecologic Oncology (NOGGO), AGO Austria and AGO Swiss)’, Archives of Gynecology and Obstetrics, 311, pp. 1451–1459. Available at: https://doi.org/10.1007/s00404-025-07974-z.

Todorov, Tihomir Zh et al. (2025) ‘Phosphoproteomics Reveals L1CAM-Associated Signaling Networks in High-Grade Serous Ovarian Carcinoma: Implications for Radioresistance and Tumorigenesis’, International Journal of Molecular Sciences, 26. Available at: https://doi.org/10.3390/ijms26104585.

Chacon, E. et al. (2025) ‘Global practice patterns of sentinel lymph node biopsy in endometrial cancer: a survey from the European Network of Young Gynecologic Oncologists (ENYGO)’, International Journal of Gynecological Cancer, 35(4), p. 100068. Available at: https://doi.org/10.1016/j.ijgc.2024.100068.

Dondi, Arthur et al. (2025) ‘De novo detection of somatic variants in high-quality long-read single-cell RNA sequencing data’, Genome Research, 35, pp. 900–913. Available at: https://doi.org/10.1101/gr.279281.124.

Geissler, Franziska et al. (2025) ‘Endocrine Maintenance Therapy in High-Grade Serous Ovarian Cancer: A Retrospective Off-Label Real-World Cohort Study’, Cancers, 17. Available at: https://doi.org/10.3390/cancers17081301.

Kacperczyk-Bartnik, J. et al. (2025) ‘Health care organization for gynecologic oncology patients fleeing Ukraine: Insights from the European Network of Young Gyne Oncologists survey during the first six months of the military conflict’, International Journal of Gynecological Cancer, 35(4), p. 101719. Available at: https://doi.org/10.1016/j.ijgc.2025.101719.

Vergote, Ignace et al. (2025) ‘Tumor Treating Fields therapy in platinum-resistant ovarian cancer: Results of the ENGOT-ov50/GOG-3029/INNOVATE-3 pivotal phase 3 randomized study’, European Journal of Cancer, 219. Available at: https://doi.org/10.1016/j.ejca.2025.115306.

Geissler, F. et al. (2025) ‘Endocrine Maintenance Therapy in High-Grade Serous Ovarian Cancer: A Retrospective Off-Label Real World Cohort Study’. MDPI AG. Available at: https://doi.org/10.20944/preprints202503.0721.v1.

Bilir, E. et al. (2025) ‘MOTIVATORS AND BARRIERS TO EXERCISE PRESCRIPTION IN GYNECOLOGIC ONCOLOGY: PRELIMINARY RESULTS FROM A EUROPEAN NETWORK OF YOUNG GYNECOLOGIC ONCOLOGISTS (ENYGO) CROSS-SECTIONAL STUDY’, International Journal of Gynecological Cancer, 35(2), p. 100954. Available at: https://doi.org/10.1016/j.ijgc.2024.100954.

Bilir, E. et al. (2025) ‘Urinary Incontinence Management In Patients With Primary Endometrial Cancer: Preliminary Results From The European Network Of Young Gynaecologic Oncologists (ENYGO) Cross-Sectional Study’, International Journal of Gynecological Cancer, 35(2), p. 101347. Available at: https://doi.org/10.1016/j.ijgc.2024.101347.

Bilir, E. et al. (2025) ‘Challenges in Surgical Randomized Controlled Trials (RCTS) in Gynaecologic Oncology: Insights from a European Network of Young Gynae Oncologists (ENYGO) Study’, International Journal of Gynecological Cancer, 35(2), p. 101710. Available at: https://doi.org/10.1016/j.ijgc.2025.101710.

Coelho, R. et al. (2025) ‘Tumor-Associated Macrophages Improve The Efficacy Of SMAC Mimetics Combined With Chemotherapy In Ovarian Cancer’, International Journal of Gynecological Cancer, 35(2), p. 101462. Available at: https://doi.org/10.1016/j.ijgc.2024.101462.

El-Hajj, H. et al. (2025) ‘Current Practices And Barriers In HRD And BRCA Testing For Ovarian Cancer: Preliminary Findings From The European Network Of Young Gynaecologic Oncologists (ENYGO) Cross-Sectional Study’, International Journal of Gynecological Cancer, 35(2), p. 101585. Available at: https://doi.org/10.1016/j.ijgc.2024.101585.

Eller, R.S. et al. (2025) ‘Secondary Debulking Followed By Localised Radiotherapy In Patients With Oligometastatic Recurrent Ovarian Cancer – A Case Series Of Two International Cancer Centres’, International Journal of Gynecological Cancer, 35(2), p. 101143. Available at: https://doi.org/10.1016/j.ijgc.2024.101143.

Fotiou, Alexandros et al. (2025) ‘Fertility Sparing Treatment In Patients With Placental Trophoblastic Site Tumor: A Systematic Review.’, International Journal of Gynecological Cancer. journal-article. Elsevier, 35(2). Available at: https://doi.org/10.1016/j.ijgc.2024.101498.

Kacperczyk-Bartnik, J. et al. (2025) ‘Prophylactic HPV Vaccination In Patients With Gynaecologic Cancer: Practices, Challenges, And Recommendations Reported In The ESGO-PERCH HPV Survey’, International Journal of Gynecological Cancer, 35(2), p. 100378. Available at: https://doi.org/10.1016/j.ijgc.2024.100378.

Kacperczyk-Bartnik, J. et al. (2025) ‘Attitudes And Practice Of Gynaecologists Regarding HPV Vaccination Of Adolescents Assessed In The ESGO-PERCH HPV Survey’, International Journal of Gynecological Cancer, 35(2), p. 101319. Available at: https://doi.org/10.1016/j.ijgc.2024.101319.

Petousis, S. et al. (2025) ‘Efficacy And Safety Of PARP Inhibitor Maintenance In Platinum-Sensitive Advanced-Stage Epithelial Ovarian Cancer: A Systematic Review And Meta-Analysis’, International Journal of Gynecological Cancer, 35(2), p. 100336. Available at: https://doi.org/10.1016/j.ijgc.2024.100336.

Tsibulak, I. et al. (2025) ‘Global survey on training and practice in sentinel lymph node mapping for endometrial and cervical cancer among early-career gynecologic oncologists’, International Journal of Gynecological Cancer, 35(2). Available at: https://doi.org/10.1016/j.ijgc.2024.100050.

Zwimpfer, T.A. et al. (2025) ‘Co-Amplification Of CCNE1 And AKT2 As Prognostic Biomarker And Therapeutic Target In Tubo-Ovarian High-Grade Serous Carcinoma’, International Journal of Gynecological Cancer, 35(2), p. 101684. Available at: https://doi.org/10.1016/j.ijgc.2025.101684.

Asberger, Jasmin et al. (2025) ‘Long non‑coding RNA signatures in breast cancer: Properties as biomarkers?’, Experimental and Therapeutic Medicine, 29(3). Available at: https://doi.org/10.3892/etm.2025.12804.

Canário, Rita et al. (2025) ‘P-cadherin overexpression is associated with early transformation of the Fallopian tube epithelium and aggressiveness of tubo-ovarian high-grade serous carcinoma’, Virchows Archiv [Preprint]. Available at: https://doi.org/10.1007/s00428-025-04104-7.

Fotiou, Alexandros et al. (2025) ‘Fertility-sparing treatment in patients with placental trophoblastic site tumor: a systematic review’, International Journal of Gynecological Cancer [Preprint]. 12.06.2025. Available at: https://doi.org/10.1016/j.ijgc.2025.101972.

Kavvadias, Tilemachos, Gosch, Emma Garcia and Heinzelmann-Schwarz, Viola (2025) ‘Robotic assisted hysterectomy and colpectomy as gender affirming surgery in trans men: an instructional video and perioperative considerations’, Frontiers in Surgery, 12. Available at: https://doi.org/10.3389/fsurg.2025.1608666.

Förster, Christiane E. et al. (2024) ‘Comparison of different suture techniques for laparoscopic vaginal cuff closure’, Scientific Reports, 14(1). Available at: https://doi.org/10.1038/s41598-024-55586-5.

Franz, Henriette et al. (2024) ‘Unbiased screening identifies regulators of cell-cell adhesion and treatment options in pemphigus’, Nature Communications, 15(1). Available at: https://doi.org/10.1038/s41467-024-51747-2.

Gottfrois, Philippe et al. (2024) ‘AI-powered visual diagnosis of vulvar lichen sclerosus: A pilot study’, Journal of the European Academy of Dermatology and Venereology, 38(12), pp. 2280–2285. Available at: https://doi.org/10.1111/jdv.20306.

Kasikova, Lenka et al. (2024) ‘Tertiary lymphoid structures and B cells determine clinically relevant T cell phenotypes in ovarian cancer’, Nature Communications, 15(1). Available at: https://doi.org/10.1038/s41467-024-46873-w.

Nesic, Ksenija et al. (2024) ‘BRCA1 secondary splice-site mutations drive exon-skipping and PARP inhibitor resistance’, Molecular Cancer, 23(1). Available at: https://doi.org/10.1186/s12943-024-02048-1.

Wegmann, Rebekka et al. (2024) ‘Single-cell landscape of innate and acquired drug resistance in acute myeloid leukemia’, Nature Communications , 15(1). Available at: https://doi.org/10.1038/s41467-024-53535-4.

Zwimpfer, Tibor A. et al. (2024) ‘Comparison of 2D 4K vs. 3D HD laparoscopic imaging systems in bariatric surgery: study protocol for a randomized controlled prospective trial’, Trials, 25(1). Available at: https://doi.org/10.1186/s13063-024-07983-4.

Zwimpfer, Tibor A. et al. (2024) ‘Comparison of 2D 4K vs. 3D HD laparoscopic imaging systems in bariatric surgery: study protocol for a randomized controlled prospective trial’, Trials, 25(1). Available at: https://doi.org/10.1186/s13063-024-07983-4.

Tundo, Sofia et al. (2024) ‘Inhibition of Cbl-b restores effector functions of human intratumoral NK cells’, Journal for ImmunoTherapy of Cancer, 12(11). Available at: https://doi.org/10.1136/jitc-2024-009860.

Speck, Nicole E. et al. (2024) ‘The Importance of Patient-Reported Outcome Measures (PROMs) in Oncological Vulvoperineal Defect Reconstruction: A Systematic Review’, Current Oncology. 25.10.2024, 31(10), pp. 6300–6313. Available at: https://doi.org/10.3390/curroncol31100470.

Zwimpfer, Tibor A et al. (2024) ‘Predictive value of homologous recombination deficiency status for survival outcomes in primary tubo-ovarian high-grade serous carcinoma’, Cochrane Database of Systematic Reviews. 23.09.2024, 2024(9). Available at: https://doi.org/10.1002/14651858.cd015896.

Labrosse, Kathrin B. et al. (2024) ‘Protocol for quantifying drug sensitivity in 3D patient-derived ovarian cancer models’, STAR Protocols, 5(3). Available at: https://doi.org/10.1016/j.xpro.2024.103274.

Kacperczyk-Bartnik, J. et al. (2024) ‘Best original research presented at the 25th European Congress on Gynaecological Oncology: Best of ESGO 2024’, International Journal of Gynecological Cancer, 34(9), pp. 1324–1333. Available at: https://doi.org/10.1136/ijgc-2024-005844.

Einig, S. et al. (2024) ‘Präoperative sonographische Beurteilung von Adnexbefunden mittels Ovarian-Adnexal Reporting & Data System (O-RADS)’, in Ultraschall in der Medizin - European Journal of Ultrasound. Salzburg (Ultraschall in der Medizin - European Journal of Ultrasound). Available at: https://doi.org/10.1055/s-0044-1789121.

Heidinger, Martin et al. (2024) ‘Association of relative resection volume with patient-reported outcomes applying different levels of oncoplastic breast conserving surgery – A retrospective cohort study’, European Journal of Surgical Oncology, 50(9), pp. 1–9. Available at: https://doi.org/10.1016/j.ejso.2024.108478.

Xu, Lijun et al. (2024) ‘High-level tumour methylation of BRCA1 and RAD51C is required for homologous recombination deficiency in solid cancers’, NAR Cancer, 6(3). Available at: https://doi.org/10.1093/narcan/zcae033.

Zwimpfer, T.A. et al. (2024) ‘752P Clinical and molecular predictors of outcome in patients with tubo-ovarian high-grade serous carcinoma and exceptional survival’, Annals of Oncology, 35, p. S571. Available at: https://doi.org/10.1016/j.annonc.2024.08.813.

Saner, F.A.M. et al. (2024) ‘Concurrent RB1 Loss and BRCA Deficiency Predicts Enhanced Immunologic Response and Long-term Survival in Tubo-ovarian High-grade Serous Carcinoma’, Clinical Cancer Research, 30(16), pp. 3481–3498. Available at: https://doi.org/10.1158/1078-0432.ccr-23-3552.

Cumin, Cécile et al. (2024) ‘Highly Sensitive Spatial Glycomics at Near-Cellular Resolution by On-Slide Derivatization and Mass Spectrometry Imaging’, Analytical Chemistry, 96(28), pp. 11163–11171. Available at: https://doi.org/10.1021/acs.analchem.3c05984.

Jelena, Vasilevska et al. (2024) ‘Monitoring melanoma patients on treatment reveals a distinct macrophage population driving targeted therapy resistance’, Cell Reports Medicine. 16.07.2024, 5(7), p. 101611. Available at: https://doi.org/10.1016/j.xcrm.2024.101611.

Vasilevska, Jelena et al. (2024) ‘Monitoring melanoma patients on treatment reveals a distinct macrophage population driving targeted therapy resistance’, Cell Reports Medicine, 5(7), p. 101611. Available at: https://doi.org/10.1016/j.xcrm.2024.101611.

Immer, Alexander et al. (2024) ‘Probabilistic pathway-based multimodal factor analysis’, Bioinformatics, 40(Supplement_1), pp. i189–i198. Available at: https://doi.org/10.1093/bioinformatics/btae216.

Dhar, Chirag et al. (2024) ‘Diagnosing and staging epithelial ovarian cancer by serum glycoproteomic profiling’, British Journal of Cancer, 130(10), pp. 1716–1724. Available at: https://doi.org/10.1038/s41416-024-02644-4.

Wendelspiess, Séverin et al. (2024) ‘Perforator versus Non-Perforator Flap-Based Vulvoperineal Reconstruction—A Systematic Review and Meta-Analysis’, Cancers. 13.06.2024, 16(12). Available at: https://doi.org/10.3390/cancers16122213.

Ge, Isabell et al. (2024) ‘Real-World Data Analysis of CDK4/6 Inhibitor Therapy—A Patient-Centric Single Center Study’, Cancers, 16(9). Available at: https://doi.org/10.3390/cancers16091760.

Ge, Isabell et al. (2024) ‘Does structured obstetric management play a role in the delivery mode and neonatal outcome of twin pregnancies?’, Archives of Gynecology and Obstetrics, 309(4), pp. 1441–1452. Available at: https://doi.org/10.1007/s00404-023-07040-6.

Grašič Kuhar, Cvetka et al. (2024) ‘Prognostic Importance of Axillary Lymph Node Response to Neoadjuvant Systemic Therapy on Axillary Surgery in Breast Cancer—A Single Center Experience’, Cancers, 16(7). Available at: https://doi.org/10.3390/cancers16071306.

Dondi, A. et al. (2024) ‘De novo detection of somatic variants in long-read single-cell RNA sequencing data’. Cold Spring Harbor Laboratory. Available at: https://doi.org/10.1101/2024.03.06.583775.

Harter, Philipp et al. (2024) ‘Statement of the AGO Kommission Ovar, AGO Study Group, NOGGO, AGO Austria, Swiss AGO, BGOG, CEEGOG, GEICO, and SFOG regarding the use of hyperthermic intraperitoneal chemotherapy (HIPEC) in epithelial ovarian cancer’, Bulletin du Cancer, 111(3), pp. 277–284. Available at: https://doi.org/10.1016/j.bulcan.2023.02.011.

Zwimpfer, Tibor A. et al. (2024) ‘Management of Patients with Hypersensitivity to Platinum Salts and Taxane in Gynecological Cancers: A Cross-Sectional Study by the European Network of Young Gynaecologic Oncologists (ENYGO)’, Cancers, 16(6). Available at: https://doi.org/10.3390/cancers16061155.

Zwimpfer, T.A. et al. (2024) Management of Patients with Hypersensitivity to Platinum Salts and Taxane in Gynecological Cancers: A Cross-Sectional Study by the European Network of Young Gynaecologic Oncologists (ENYGO). MDPI AG. Available at: https://doi.org/10.20944/preprints202402.1168.v1.

Labrosse, Kathrin B. et al. (2024) ‘Intracorporeal vs. extracorporeal open and closed knot tying techniques in laparoscopy: A randomized, controlled study’, Heliyon. 26.01.2024, 10(3), p. e25178. Available at: https://doi.org/10.1016/j.heliyon.2024.e25178.

Coelho, Ricardo et al. (2024) ‘SMAC mimetics overcome apoptotic resistance in ovarian cancer through MSLN-TNF alpha axis’. Cold Spring Harbor Laboratory. Available at: https://doi.org/10.1101/2024.01.24.576987.

Einig, Sabrina et al. (2024) ‘Pelvic Pain of Myofascial Origin in Women: Correlation with Lower Urinary Tract Symptoms’, Advances in Urology, 2024. Available at: https://doi.org/10.1155/2024/5568010.

Geissler, F. et al. (2024) ‘The role of aberrant DNA methylation in cancer initiation and clinical impacts’, Therapeutic Advances in Medical Oncology, 16. Available at: https://doi.org/10.1177/17588359231220511.

Stiegeler, Nadja et al. (2024) ‘Homologous recombination proficient subtypes of high-grade serous ovarian cancer: treatment options for a poor prognosis group’, Frontiers in Oncology, 14. Available at: https://doi.org/10.3389/fonc.2024.1387281.

Zwimpfer, T.A. et al. (2024) ‘Desensitization in patients with hypersensitivity to platinum and taxane in gynecological cancers’, Cancer Medicine, 13(1). Available at: https://doi.org/10.1002/cam4.6840.

Zwimpfer, T.A. et al. (2023) ‘Comparison of 2D 4K vs. 3D HD laparoscopic imaging systems in bariatric surgery: study protocol for a randomized controlled prospective trial’. Research Square Platform LLC. Available at: https://doi.org/10.21203/rs.3.rs-3422145/v1.

Kacperczyk-Bartnik, J. et al. (2023) ‘Best original research presented at the 24th European Congress on Gynaecological Oncology—Best of ESGO 2023’, International Journal of Gynecological Cancer, 34(4), pp. 610–618. Available at: https://doi.org/10.1136/ijgc-2023-005132.

Herzog, Emilie M et al. (2023) ‘How to break bad news and how to learn this skill: Results from an international North-Eastern German Society for Gynecological Oncology (NOGGO) survey among physicians andthe physicians are generally alone with the patient; Only 57.4% medical students with 1089 participants’, International Journal of Gynecological Cancer, 33(12), pp. 1934–1942. Available at: https://doi.org/10.1136/ijgc-2023-004693.

Zwimpfer, Tibor A. et al. (2023) ‘Contralateral lymph node metastasis in recurrent ipsilateral breast cancer with Lynch syndrome: a locoregional event’, World Journal of Surgical Oncology, 21(1). Available at: https://doi.org/10.1186/s12957-023-02918-w.

Saner, F.A.M. et al. (2023) ‘Concurrent RB1 loss and BRCA -deficiency predicts enhanced immunological response and long-term survival in tubo-ovarian high-grade serous carcinoma’. Cold Spring Harbor Laboratory. Available at: https://doi.org/10.1101/2023.11.09.23298321.

Woopen, Hannah et al. (2023) ‘Side Effects from Cancer Therapies and Perspective of 1044 Long-Term Ovarian Cancer Survivors—Results of Expression VI–Carolin Meets HANNA–Holistic Analysis of Long-Term Survival with Ovarian Cancer: The International NOGGO, ENGOT, and GCIG Survey’, Cancers, 15(22). Available at: https://doi.org/10.3390/cancers15225428.

Asberger, Jasmin et al. (2023) ‘In Vitro microRNA Expression Profile Alterations under CDK4/6 Therapy in Breast Cancer’, Biomedicines, 11(10). Available at: https://doi.org/10.3390/biomedicines11102705.

Chinczewski, L. et al. (2023) ‘#435 Changes of lifestyle, exercise of precaution and preferences – interim results of an international survey for endometrial cancer patients (NOGGO, ENGOT, GCIG – expression XI/IMPROVE)’. BMJ Publishing Group Ltd, p. A159.3–A160. Available at: https://doi.org/10.1136/ijgc-2023-esgo.328.

Zwimpfer, T.A. et al. (2023) ‘#70 Influence of predictive features on therapy response and survival in high-grade serous ovarian cancer patients by germline BRCA mutation status: an update from the australian ovarian cancer study’. BMJ Publishing Group Ltd, p. A36.1–A36. Available at: https://doi.org/10.1136/ijgc-2023-esgo.56.

Zwimpfer, T.A. et al. (2023) ‘#71 Integrated multi-omic and clinicopathological analysis of high-grade serous ovarian cancer in BRCA1/2 mutated patients with poor survival: identification of predictive biomarkers for personalized treatment’. BMJ Publishing Group Ltd, p. A32.2–A33. Available at: https://doi.org/10.1136/ijgc-2023-esgo.49.

Zwimpfer, T.A. et al. (2023) ‘#174 Integrated multi-omic and clinicopathological analysis of vulvar squamous cell carcinoma: identification of predictive biomarkers for personalized treatment’. BMJ Publishing Group Ltd, p. A364.1–A364. Available at: https://doi.org/10.1136/ijgc-2023-esgo.773.

Förster, C. et al. (2023) ‘Comparison of different suture techniques for laparoscopic vaginal cuff closure’. Research Square Platform LLC. Available at: https://doi.org/10.21203/rs.3.rs-3183763/v1.

Starzonek, Sarah et al. (2023) ‘Identification of potential classes of glycoligands mediating dynamic endothelial adhesion of human tumor cells’, Glycobiology, 33(8), pp. 637–650. Available at: https://doi.org/10.1093/glycob/cwad061.

Geissler, F. et al. (2023) ‘Adherence to multidisciplinary team meeting recommendations in elderly patients with HER2-positive breast cancer’. Research Square Platform LLC. Available at: https://doi.org/10.21203/rs.3.rs-3107172/v1.

Knipprath-Mészáros, Alexandra Maria et al. (2023) ‘High negative prediction for the Basel sarcoma score: Sonographic assessment of features suspicious of uterine sarcoma’, Gynecologic Oncology, 174, pp. 182–189. Available at: https://doi.org/10.1016/j.ygyno.2023.05.005.

Rimmer, Natalie et al. (2023) ‘Generation of endogenously tagged E-cadherin cells using gene editing via non-homologous end joining’, STAR Protocols, 4(2). Available at: https://doi.org/10.1016/j.xpro.2023.102305.

Chinczewski, L. et al. (2023) ‘Patients with endometrial cancer: Expectations and preferences towards therapy and quality of life—First results of an international survey (NOGGO, ENGOT, GCIG - IMPROVE/EXPRESSION XI).’, Journal of Clinical Oncology, 41(16_suppl), pp. e24120–e24120. Available at: https://doi.org/10.1200/jco.2023.41.16_suppl.e24120.

Colombo, N. et al. (2023) ‘INOVATYON/ ENGOT-ov5 study: Randomized phase III international study comparing trabectedin/pegylated liposomal doxorubicin (PLD) followed by platinum at progression vs carboplatin/PLD in patients with recurrent ovarian cancer progressing within 6-12 months after last platinum line’, British Journal of Cancer, 128(8), pp. 1503–1513. Available at: https://doi.org/10.1038/s41416-022-02108-7.